Global Health Limited reported a 26% revenue jump in Q1 FY27, though net profit saw a slight dip due to higher expansion-related costs. The hospital chain is moving ahead with a massive Rs 4,850 crore plan to add 3,350 beds over five years. Investors are monitoring how quickly new facilities like Noida reach profitability as the company balances rapid growth with rising depreciation and interest expenses.
Global Health Limited, the company behind the Medanta hospital chain, reported strong operational growth for the first quarter of fiscal year 2027. Revenue from operations and core operating profit (EBITDA) rose by 26 percent and 25 percent respectively compared to the same period last year. This growth was driven by a sharp 27.7 percent rise in in-patient volumes and a 34.5 percent increase in out-patient footfalls. Furthermore, the Average Revenue Per Occupied Bed, a key measure of hospital efficiency, climbed by 5.5 percent to Rs 70,244.
Despite these gains, the company’s net profit saw a slight decline. This is largely linked to increased depreciation and higher finance costs resulting from aggressive spending on new hospitals. As the company builds out its network, these costs often rise before the new facilities begin generating meaningful profit. The consolidated EBITDA margin settled at 22.5 percent for the quarter, reflecting the initial pressure of scaling up newer units.
Noida Hospital and Future Growth Engines
The Noida hospital unit is a primary focus for investors. While it has been an earnings drag in previous periods, it is now showing signs of turning around. In Q1, the facility's income rose to Rs 85.5 crore from Rs 52.5 crore in the previous quarter, with its operating loss narrowing significantly to Rs 4.9 crore. With 433 of its planned 550 beds currently operational, the continued ramp-up of this unit is expected to be a major factor in the company’s future margin profile.
Expansion and Capital Spending
Medanta has announced an ambitious five-year capital spending plan totaling Rs 4,850 crore. This money is dedicated to adding 3,350 beds across several cities, including Varanasi, Guwahati, Mumbai, and South Delhi, where the company is partnering with DLF. This strategy represents a significant increase in the company's footprint, taking its installed base beyond the 3,737 beds reported at the end of Q1.
For investors, the long-term outlook depends on the company's ability to execute these projects on time and maintain high service quality across new locations. While the expansion supports long-term revenue potential, it also requires disciplined management of debt and operational costs. The company’s ability to balance its established, high-performing centers in Gurugram, Indore, and Ranchi with the developing portfolio in Lucknow, Patna, and Noida will remain a key monitorable. Investors will likely look for updates on project timelines, the stabilization of the Noida unit's margins, and the impact of the rising depreciation load on bottom-line profitability in the coming quarters.